Guidance and quality standards Awaiting development

Skip to filtersSkip to results

Skip to results

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme 1 selected

Guidance programme

Showing 281 to 284 of 284

TitleType
Zanidatamab for treating HER2-positive advanced biliary tract cancer after 1 or more systemic treatments TS ID 11952Technology appraisal guidance
Zanubrutinib with obinutuzumab for treating relapsed or refractory B-cell follicular lymphoma after 2 or more treatments TSID 11915Technology appraisal guidance
Zavegepant for treating acute migraine TSID 11998Technology appraisal guidance
Zuranolone for treating severe postnatal depression ID6431Technology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All